SureCN7249538 (CID 12858253) - BioAssay Data Summary for Compound
.
BioActivity Outcomes:
Active(3)
 
 
Unspecified(4)
 
 
BioAssay Types:
Literature(7)
 
 
 
BioActivity Types:
IC50(2)
 
 
SAR
Target summary
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 7    Data Row: 7   Total Pages: 1   
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103682696]
IC50 3.49Antiviral activity against HRV 1B infected in human HeLa Ohio cells assessed as reduction in viral plaque formation after 3 days by neutral red uptake assay [AID424989, Type: Literature]
View
2
[SID103682696]
IC50 25Antiviral activity against HRV 14 infected in human HeLa Ohio cells assessed as reduction in viral plaque formation after 3 days by neutral red uptake assay [AID424991, Type: Literature]
View
3
[SID103682696]
 Cytotoxicity against human HeLa Ohio cells assessed as maximal non-cytotoxic concentration after 3 days by XTT assay [AID424988, Type: Literature]
View
4
[SID103682696]
 Cytotoxicity against human HeLa Ohio cells after 3 days by XTT assay [AID424987, Type: Literature]
View
5
[SID103682696]
 Antiviral activity against HRV 1B infected in human HeLa Ohio cells assessed as reduction in viral plaque formation at maximum non-cytotoxic concentration after 3 days by neutral red uptake assay [AID424990, Type: Literature]
View
6
[SID103682696]
 Antiviral activity against HRV 14 infected in human HeLa Ohio cells assessed as reduction in viral plaque formation at maximum non-cytotoxic concentration after 3 days by neutral red uptake assay [AID424992, Type: Literature]
View
7
[SID103682696]
 Therapeutic index, ratio of TC50 for human HeLa Ohio cells to IC50 for HRV1B infected in human HeLa Ohio cells [AID424993, Type: Literature]
View